nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2013-17-1-111-112nefr-542Research ArticleПИСЬМА В РЕДАКЦИЮLETTERS TO THE EDITORДЕПОЗИТЫ C1q И C1q-НЕФРОПАТИЯC1q DEPOSITS AND C1q-NEPHROPATHYДобронравовВ. А.DobronravovV. A.
197022, Санкт-Петербург, ул. Л. Толстого, д. 17
dobronravov@nephrolog.ruНаучно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. ПавловаRussian Federation201310012013171111112Copyright © Добронравов В.А., 20132013Добронравов В.А.Dobronravov V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/542
Депозиты C1q и C1q-нефропатия.
C1q deposits and C1q-nephropathy.
ReferencesБатюшин ММ, Галушкин АА, Пасечник ДГ и др. Клинический случай С1q-нефропатии. Нефрология 2012; 16(3): 117-121Батюшин ММ, Галушкин АА, Пасечник ДГ и др. Клинический случай С1q-нефропатии. Нефрология 2012; 16(3): 117-121Jennette JC, Hipp CG: Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 1985; 83: 415-420Jennette JC, Hipp CG: Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 1985; 83: 415-420Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 1985;6:103-10Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 1985;6:103-10Vizjak A, Ferluga D, Rožič М et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 2008; 19(11): 2237-2244Vizjak A, Ferluga D, Rožič М et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 2008; 19(11): 2237-2244Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD: C1q nephropathy: a variant of segmental glomerulosclerosis. Kidney Int 2003; 64: 1232-1240Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD: C1q nephropathy: a variant of segmental glomerulosclerosis. Kidney Int 2003; 64: 1232-1240Hisano S, Fukuma Y, Segawa Y et al. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol 2008;3:1637-1643Hisano S, Fukuma Y, Segawa Y et al. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol 2008;3:1637-1643Добронравов ВА. Гипокомплементемический уртикарный васкулит: введение в клинику и иммунобиологию Нефрология 2011; 15(1): 17-26Добронравов ВА. Гипокомплементемический уртикарный васкулит: введение в клинику и иммунобиологию Нефрология 2011; 15(1): 17-26Emancipator SN. Benign essential hematuria, IgA nephropathy, and Alport syndrome. In: Renal Biopsy Interpretation, eds Silva FG, D’Agati VD, Nadasdy T, Churchill Livingstone, New York, 1996; 147-180Emancipator SN. Benign essential hematuria, IgA nephropathy, and Alport syndrome. In: Renal Biopsy Interpretation, eds Silva FG, D’Agati VD, Nadasdy T, Churchill Livingstone, New York, 1996; 147-180Nishida M, Kawakatsu H, Komatsu H et al. Spontaneous improvement in a case of C1q nephropathy. Am J Kidney Dis 2000 May;35(5):E22Nishida M, Kawakatsu H, Komatsu H et al. Spontaneous improvement in a case of C1q nephropathy. Am J Kidney Dis 2000 May;35(5):E22Castellano G, Melchiorre R, Loverre A et al. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol 2010;176(4):1648-1659Castellano G, Melchiorre R, Loverre A et al. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol 2010;176(4):1648-1659Thurman JM, Renner B. Dynamic control of the complement system by modulated expression of regulatory proteins Lab Invest 2011; 91(1): 4-11Thurman JM, Renner B. Dynamic control of the complement system by modulated expression of regulatory proteins Lab Invest 2011; 91(1): 4-11
The authors declare that there are no conflicts of interest present.